Patient safety is a universal challenge. World Health Organization (WHO) endorsed resolutions and launched programs to eliminate avoidable harm in healthcare and blood transfusion:
Universal Health Coverage – access to affordable healthcare for all
Model Lists: Essential Medicines; in vitro Diagnostics including blood products and test kits – access to affordable medicines and diagnostics
Resolution 72.6 Global action on patient safety – Global Patient Safety Action Plan 2021-2030 includes blood transfusion.
Annually millions of patients suffer injuries or die because of unsafe and poor-quality healthcare including unsafe blood transfusion and poor practices; ±134 million adverse events occur each year due to unsafe care in hospitals in poor economics countries, causing 2.6 million deaths/year to which poor and unsafe transfusion practices contribute. The session will discuss these programs and the role of safe and evidence-based transfusion in eliminating avoidable patient harm.
To view Spanish or English subtitles, click the "CC" box in the video player. Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Recognize the importance of the WHO resolutions and programs to develop safe and evidence-based transfusion practices to eliminate avoidable patient harm.
Discuss the key governance and stewardship elements needed to develop availability of a safe, and efficacious blood transfusion system.
Explain the role of safe blood transfusion in eliminating avoidable patient harm
World Health Organization Regional Office for the Eastern Mediterranean
All relevant financial relationships have been mitigated. By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
AM21-54: World Health Organization Programs to Develop Improved Global Transfusion Practices and Patient Safety Evaluation